Anticoagulation use is associated with lower fetal fraction and more indeterminate results
American Journal of Obstetrics and Gynecology · 2024
DOI: 10.1016/j.ajog.2023.07.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Obstetrics and Gynecology, 2024. Verfasst von Raj Shree und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA. Electronic address: shreer23@uw.…. Hauptthemen laut MEDLINE: Cell-Free Nucleic Acids, Autoimmune Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Maternal anticoagulation use may increase indeterminate result rates on cell-free DNA-based screening, but existing studies are confounded by inclusion of individuals with autoimmune disease, which alone is associated with indeterminate results. Changes in chromosome level Z-scores are proposed by others as a reason for indeterminate results, but the etiology of this is uncertain. OBJECTIVE: This study aimed to evaluate differences in fetal fraction, indeterminate result rate, and total cell-free DNA concentration in individuals on anticoagulation without autoimmune disease compared with controls undergoing noninvasive prenatal screening. Secondly, using a nested case-control design, we evaluated differences in fragment size, GC-content, and Z-scores to evaluate laboratory-level test characteristics. STUDY DESIGN: This was a retrospective single-institution study of pregnant individuals undergoing cell-free DNA-based noninvasive prenatal screening using low-pass whole-genome sequencing between 2017 and 2021. Individuals with autoimmune disease, suspected aneuploidy, and cases where fetal fraction was not reported were excluded. Anticoagulation included heparin-derived products (unfractionated heparin, low-molecular-weight heparin), clopidogrel, and fondaparinux, with a separate group for those on aspirin alone. An indeterminate result was defined as fetal fraction 8-fold increase in the likelihood of an indeterminate result (adjusted odds ratio, 8.7; 95% confidence interval, 3.1-24.9; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA. Electronic address: shreer23@uw.edu.
- Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA.
- University of Washington School of Medicine, University of Washington, Seattle, WA.
- Department of Laboratory Medicine & Pathology, University of Washington, Seattle, WA.
Förderung
- NHLBI NIH HHS
- NIGMS NIH HHS
- NCATS NIH HHS
- National Institutes of Health
- National Heart, Lung, and Blood Institute
- National Center for Advancing Translational Sciences
Zitieren
APA
Shree, R., MacKinnon, H. J., Hannan, J., Kolarova, T. R., Reichel, J., & Lockwood, C. M. (2024). Anticoagulation use is associated with lower fetal fraction and more indeterminate results. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/j.ajog.2023.07.005
Vancouver
Shree R, MacKinnon HJ, Hannan J, Kolarova TR, Reichel J, Lockwood CM. Anticoagulation use is associated with lower fetal fraction and more indeterminate results. American Journal of Obstetrics and Gynecology. 2024. doi:10.1016/j.ajog.2023.07.005
BibTeX
@article{Shree2024,
author = {Shree, Raj and MacKinnon, Hayley J and Hannan, Joely and Kolarova, Teodora R and Reichel, Jonathan and Lockwood, Christina M},
title = {Anticoagulation use is associated with lower fetal fraction and more indeterminate results},
journal = {American Journal of Obstetrics and Gynecology},
year = {2024},
doi = {10.1016/j.ajog.2023.07.005}
}
EUVIMED